Basket | Login | Register

 
 
 
 

LM11A-31-BHS (coming soon)

Phase II trials

Scientific title

Study of LM11A-31-BHS in patients with mild to moderate probable Alzheimer's disease

Study sponsor

PharmatrophiX Inc.

Disease

Alzheimer’s disease

Phase

Phase IIa

Name of drug

LM11A-31-BHS

Link to full text

https://clinicaltrials.gov/ct2/show/NCT03069014

Please note that an accessible easy read version of this study is not yet available. The pharmaceutical company running this trial and a member of the European Working Group of People with Dementia are currently reviewing this document.

 

 
 

Last Updated: Thursday 07 February 2019

 

 
  • Acknowledgements

    Alzheimer Europe's Clinical Trial Watch received funding under an operating grant from the European Union’s Health Programme (2014–2020).
  • European Union
 
 

Options